HIV Antibody Screening of Blood Donations: ELISA Algorithm and Safety
Blood supply safety relies on serologic and nucleic acid testing (NAT).
Algorithm
- Donor screening questionnaire (behavioral risk deferral).
- Sample collection → plasma/serum separation.
- Fourth-generation HIV Ag/Ab combo assay (ELISA/CMIA): Detects p24 antigen (early) + anti-HIV-1/2 antibodies.
- Reactive → repeat in duplicate.
- Repeatedly reactive → confirmatory testing: HIV-1/HIV-2 differentiation assay (Geenius, Multispot) or Western blot (historical).
- NAT (minipool or individual): Detects HIV RNA ~10 days post-infection (window period reduction).
Quality Assurance
Positive/negative controls each run; proficiency testing; lookback/traceback for seroconverting donors. Residual risk in US: ~1 in 1.5–2 million donations.
HIV & AIDS - Related Articles
- AIDS and HIV: How Immune Destruction Leads to Opportunistic Diseases
- Biktarvy for HIV: Mechanism, Efficacy & Clinical Profile
- Understanding Rapid HIV Test Results: A Comprehensive Guide
- HIV-Associated Sensory Impairment: Eyes and Ears
- HIV Survival Outside the Body: Understanding Risk in Saliva
- HIV Risk from Needlestick Injury: Probability and Post-Exposure Protocol
- HIV Transmission Myths: Mosquito Bites and Ingestion Cannot Spread HIV
